[go: up one dir, main page]

NO20080704L - New salts of rosiglitazone - Google Patents

New salts of rosiglitazone

Info

Publication number
NO20080704L
NO20080704L NO20080704A NO20080704A NO20080704L NO 20080704 L NO20080704 L NO 20080704L NO 20080704 A NO20080704 A NO 20080704A NO 20080704 A NO20080704 A NO 20080704A NO 20080704 L NO20080704 L NO 20080704L
Authority
NO
Norway
Prior art keywords
rosiglitazone
new salts
salts
new
enantiomeric
Prior art date
Application number
NO20080704A
Other languages
Norwegian (no)
Inventor
Udo Werz
Gerhard Maas
Heinrich Stahl
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of NO20080704L publication Critical patent/NO20080704L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Noodles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to novel amino acid salts of the racemic or an enantiomeric or tautomeric form of rosiglitazone and to the solvates of said salts.
NO20080704A 2005-07-22 2008-02-07 New salts of rosiglitazone NO20080704L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034406A DE102005034406A1 (en) 2005-07-22 2005-07-22 New salts of rosiglitazone
PCT/EP2006/007171 WO2007009799A1 (en) 2005-07-22 2006-07-20 Amino acid salts of rosiglitazone

Publications (1)

Publication Number Publication Date
NO20080704L true NO20080704L (en) 2008-02-07

Family

ID=36870547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080704A NO20080704L (en) 2005-07-22 2008-02-07 New salts of rosiglitazone

Country Status (18)

Country Link
US (1) US20080207700A1 (en)
EP (1) EP1907386B1 (en)
JP (1) JP2009502760A (en)
KR (1) KR20080032108A (en)
CN (1) CN101228157A (en)
AT (1) ATE469896T1 (en)
AU (1) AU2006271863A1 (en)
BR (1) BRPI0613686A2 (en)
CA (1) CA2616031A1 (en)
DE (2) DE102005034406A1 (en)
EA (1) EA012594B1 (en)
ES (1) ES2344662T3 (en)
IL (1) IL188661A0 (en)
NO (1) NO20080704L (en)
NZ (1) NZ565159A (en)
UA (1) UA92354C2 (en)
WO (1) WO2007009799A1 (en)
ZA (1) ZA200800184B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
EA022924B1 (en) 2009-04-03 2016-03-31 Ф.Хоффманн-Ля Рош Аг SOLID FORM OF PROPANE-1-SULFONIC ACID {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUOROPHENYL}AMIDE AND USE THEREOF
TW201041888A (en) * 2009-05-06 2010-12-01 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
MA33975B1 (en) 2009-11-06 2013-02-01 Plexxikon Inc COMPOUNDS AND METHODS FOR MODULATING KINASES AND THEIR INDICATIONS FOR USE
JP5941069B2 (en) 2011-02-07 2016-06-29 プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． Compounds and methods for kinase regulation and indications therefor
US9030870B2 (en) * 2011-08-26 2015-05-12 Micron Technology, Inc. Threshold voltage compensation in a multilevel memory
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US9815777B2 (en) * 2013-09-22 2017-11-14 Jiva Pharma, Inc. Metformin salts to treat Type2 diabetes
CN107789352A (en) * 2017-10-25 2018-03-13 桂林浩新科技服务有限公司 A kind of compound medicinal formulation and prepare treatment hyperglycaemia, high fat of blood medicine in application
CN109053717B (en) * 2018-08-09 2022-05-31 天津理工大学 A kind of rosiglitazone gentisate and preparation method thereof
CN109053718B (en) * 2018-08-09 2022-06-03 天津理工大学 A kind of rosiglitazone saccharin salt and preparation method thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB0014006D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0019224D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021865D0 (en) * 2000-09-06 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
JP2004520326A (en) * 2000-12-22 2004-07-08 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione mesylate salt
SI1448559T1 (en) * 2001-11-21 2007-06-30 Smithkline Beecham Plc 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
AU2002343052A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. Rosiglitazone edisylates and their use as antidiabetics
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129851D0 (en) * 2001-12-13 2002-01-30 Smithkline Beecham Plc Novel compounds
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130510D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2003269483A1 (en) * 2003-09-10 2005-03-29 Biocon Limited Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione

Also Published As

Publication number Publication date
BRPI0613686A2 (en) 2011-01-25
CA2616031A1 (en) 2007-01-25
AU2006271863A1 (en) 2007-01-25
NZ565159A (en) 2010-01-29
DE102005034406A1 (en) 2007-02-01
WO2007009799A1 (en) 2007-01-25
EP1907386A1 (en) 2008-04-09
EA200800065A1 (en) 2008-08-29
IL188661A0 (en) 2008-08-07
ES2344662T3 (en) 2010-09-02
EP1907386B1 (en) 2010-06-02
UA92354C2 (en) 2010-10-25
CN101228157A (en) 2008-07-23
ZA200800184B (en) 2009-02-25
EA012594B1 (en) 2009-10-30
US20080207700A1 (en) 2008-08-28
DE502006007113D1 (en) 2010-07-15
JP2009502760A (en) 2009-01-29
ATE469896T1 (en) 2010-06-15
KR20080032108A (en) 2008-04-14

Similar Documents

Publication Publication Date Title
NO20080704L (en) New salts of rosiglitazone
UA109547C2 (en) COMPOSITION FOR CONTROL OF PLANT DISEASE AND METHOD OF CONTROL OF PLANT DISEASE
NO20080897L (en) Salts of 4-methyl-N- [3- (4-methylimidazol-1-yl) -5-trifluoromethylphenyl] -3- (4-pyridin-3-ylpyrimidin-2-ylamino) benzamide
EA201001359A1 (en) HETEROCYCLIC COMPOUNDS AS CXCR2 INHIBITORS
NO20081797L (en) New solfonyl pyrrols as inhibitors of HDAC
CR20120053A (en) JAK DE PIRAZOLOPIRIMIDINA INHIBITING COMPOUNDS AND METHODS
DE602006010243D1 (en) 4- (phenylamino) -6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative disorders
CY1110010T1 (en) PYRIDINAMINOSULPHONYL SUBSTITUTED BENZAMYMS AS PYRochIN P450 3A4 INHIBITORS (CYP3A4)
UA102336C2 (en) N1-PYRAZOLSPIRACETONS AS ACETYL-COA-CARBOXYLASE INHIBITORS
EA201100689A1 (en) N-SULPHONYLPIRROLES AND THEIR APPLICATION AS INHIBITORS HISTONDEZETYLASES
EA200900779A1 (en) DIHYDROPYRIDINE DERIVATIVES USEFUL AS PROTEKINKINASE INHIBITORS
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
NO20073368L (en) Amide prodrug of gemcitabine, compositions and use thereof
ATE400567T1 (en) KINASE INHIBITORS
EA200701396A1 (en) TRIAZOLOPHTHALASINS AS PDE-2 INHIBITORS
NZ579928A (en) Fluorinated derivatives of deferiprone
EA201200891A1 (en) DERIVATIVES 3,4,4A, 10D-TETRAGIDRO-1H-TIOPIRANO [4,3-C] IZOHINOLINA
EA200802383A1 (en) POLYMORPHIC FORMS N-HYDROXY-3- [4 - [[[2- (2-METHYL-1H-INDOL-3-IL) ETHYL] AMINO] METHYL] PHENYL] -2E-2-ACRYLAMIDE
DK2169050T3 (en) Process for the preparation of non-allergic probiotic bacterial cultures and their use
TW200745027A (en) Novel sulphonylpyrroles
ATE483000T1 (en) NAPHTALINE-AMIDINE-IMIDE
NO20080661L (en) Novel cysteine protease inhibitors and their therapeutic applications
EA201200322A1 (en) Methylpyrrolopyrimidine carboxamide
EA200801366A1 (en) DERIVATIVES 3,6-DIGIDRO-2-OXO-6N-1,3,4-TIADIAZINA
EA200801365A1 (en) SUBSTITUTED 5-PHENYL-3,6-DIGIDRO-2-OXO-6H-1,3,4-TIADIAZINS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application